Press Releases
RMTC Board Recommends Policy on the Implementation of Anabolic/Androgenic Steroid Regulations3/26/08
RMTC
NEWS RELEASE
March 26, 2008
Contact: Hallie Roach (859) 224-2848
RMTC BOARD RECOMMENDS POLICY ON THE IMPLEMENTATION OF ANABOLIC/ANDROGENIC STEROID REGULATIONS
The board of directors of the Racing Medication and Testing Consortium (RMTC), in consultation with the RMTC Scientific Advisory Committee, unanimously adopted on Tuesday several policy recommendations that it will forward on to regulators, horsemen and veterinarians.
The action took place at an RMTC board meeting Tuesday, March 25, in Austin, Texas.
The recommendations are as follows:
1. When a state racing commission implements the RMTC and RCI Androgenic Anabolic Steroid Model Rule, there should be a 90-day grace period before the penalty enforcement begins; subsequent penalties should be in accord with the RMTC and RCI Uniform Model Penalties. The trainer and owner should be notified if there is an anabolic steroid overage during the 90-day grace period.
2. The androgenic anabolic steroids boldenone, nandrolone, stanozolol and testosterone shall not be administered within 30 days prior to a race.
According to RMTC Chairman Dr. Robert Lewis, “This policy essentially imposes a prohibition on the use of all anabolic steroids within 30 days of a race. We recommend strict requirements for the administration of the four permitted anabolic steroids only by licensed veterinarians outside the 30-day prohibition period. I believe the use of anabolic steroids will be substantially reduced, which is what all of us are trying to accomplish.”
The RMTC is one of the sponsors of a workshop on the detection of androgenic/anabolic steroids in the race horse to be held at the University of California at Davis Kenneth L. Maddy Equine Analytical Chemistry Laboratory on April 27-30.
“The response of the racing chemists has been phenomenal,” said Lewis. “Over 40 participants from 28 laboratories worldwide have pre-registered for the workshop, including chemists from Brazil, Chile, England, Greece, Belgium, Canada, Jamaica and almost every U.S. racing laboratory.”
The keynote speakers will be Dr. Don Catlin, director of the Anti-Doping Research Institute and former director of the UCLA Olympic Laboratory, and Dr. Ed Houghton, formerly of Horseracing Forensic Laboratory in Newmarket, England, and one of the world’s foremost experts in anabolic steroid testing in the racehorse.
Dr. Scott Stanley, associate professor in charge of equine drug testing at the UC-Davis Maddy Lab noted, “This is an unprecedented situation where we have a new model rule coming forward and the laboratories working on uniform testing at the same time. This meets two of RMTC’s primary goals regarding uniform testing and model rule implementation. The bottom line is that you cannot have model rules without uniform testing.”
The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred and American Quarter Horse racing. The organization works to develop, promote and coordinate, at the national level, policies, research, and educational programs that seek to ensure the fairness and integrity of racing, the health and welfare of racehorses and participants, and protect the interests of the betting public.
For additional information, visit the RMTC website at www.rmtcnet.com or contact Hallie Roach, RMTC communications coordinator, (859) 224-2848.
-30-








